Innovative Therapies Days
October 9-10, 2025 | Besançon, France
We are excited to share that we will attend and speak at Innovative Therapies Days. This annual conference brings together clinicians, scientists, and industry partners dedicated to advancing innovative therapies, from their development and production to regulatory oversight.
Join us for our presentation, “From Bench to Bedside: Regulatory Strategies and Development Tools to Streamline the Transition from Non-Clinical to Clinical for Emerging Biotechs.” Take this opportunity to meet our delegates on-site and learn how our cross-functional team can support you at every stage of your innovative therapy development, from study design and data management to regulatory compliance.
About Our Presentation
From Bench to Bedside: Regulatory Strategies and Development Tools to Streamline the Transition from Non-Clinical to Clinical for Emerging Biotechs
October 9 | 17:00
For early-stage biotechs and academic researchers, transitioning from non-clinical to clinical development is a pivotal scientific and strategic step. This presentation will clarify the regulatory landscape and share practical tools and strategies to support a streamlined, risk-mitigated path to first-in-human trials in the US and EU. We’ll show how regulatory tools can accelerate development, enable evidence-based decisions, and highlight milestones essential for both drug development progression and early-stage funding.
Join us for actionable insights to bridge the gap between discovery and clinical development, reducing risk, improving efficiency, and enhancing credibility with both regulators and investors.
Meet Our Speaker
Senior Director, Regulatory Affairs
With 15 years of experience in healthcare focused on regulatory and drug development strategy, Damia helps companies to optimize their global development programs. She brings a background in global pharmaceutical companies, extensive experience dealing with health agencies, and in-depth knowledge of EU regulatory process pathways, along with training as a pharmacist and a Master’s degree in regulatory affairs from Université de Lille.
Meet Our Delegates
Esmaa Oulhissane
Business Development Manager
Marie-Aude Ohresser
Senior Vice President, Regulatory Affairs
Subscribe to our newsletter for the latest news, events, and thought leadership